Skip to main content
I-Mab (IMAB)
NASDAQ: IMAB · IEX Real-Time Price · USD
1.750
-0.020 (-1.13%)
At close: May 17, 2024, 4:00 PM
1.800
+0.050 (2.86%)
After-hours: May 17, 2024, 4:28 PM EDT

I-Mab Market Cap

I-Mab has a market cap or net worth of $134.79 million as of May 17, 2024. Its market cap has decreased by -47.26% in one year.

Market Cap
134.79M
Enterprise Value
-171.11M
1-Year Change
-47.26%
Ranking
#3912
Category
Micro-Cap
Stock Price
$1.75

Market Cap Chart

Since January 17, 2020, I-Mab's market cap has decreased from $720.80M to $134.79M, a decrease of -81.30%. That is a compound annual growth rate of -32.10%.

History

DateMarket Cap% Change
May 16, 2024142.80M-2.79%
May 15, 2024146.90M-1.61%
May 14, 2024149.30M2.19%
May 13, 2024146.10M1.74%
May 10, 2024143.60M-1.71%
May 9, 2024146.10M1.11%
May 8, 2024144.50M-1.63%
May 7, 2024146.90M1.66%
May 6, 2024144.50M1.76%
May 3, 2024142.00M-0.28%
May 2, 2024142.40M-
May 1, 2024142.40M-0.28%
Apr 30, 2024142.80M-1.72%
Apr 29, 2024145.30M-
Apr 26, 2024145.30M-0.55%
Apr 25, 2024146.10M-
Apr 24, 2024146.10M0.55%
Apr 23, 2024145.30M-
Apr 22, 2024145.30M-
Apr 19, 2024145.30M-
Apr 18, 2024145.30M-0.55%
Apr 17, 2024146.10M1.11%
Apr 16, 2024144.50M-0.55%
Apr 15, 2024145.30M-0.55%
Apr 12, 2024146.10M-
View and export this data all the way back to 2020. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
BioAtla 136.89M
Renovaro Biosciences 136.53M
Tevogen Bio Holdings 136.25M
Seer, Inc. 135.39M
Karyopharm Therapeutics 135.37M
TruBridge 134.09M
Adicet Bio 133.12M
Quipt Home Medical 132.82M
Market Cap Rankings